GGrantIndex
Sort

82,697 grants matching vaccine development

BSL3 management and practice of infectious disease research at HTRL

$2,469,118
Dominique M Missiakas · University Of Chicago · UC7 · FY2023 · AI

The Danger Model, and how tissues control Immunity

$2,469,012
Polly C Matzinger · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI

Pitt-Ohio State Clinical Trials Unit

$2,468,833
John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2023 · AI

Core 2: Biocontainment and Immune Monitoring Core

$2,468,103
Gregory D Sempowski · Duke University · P01 · FY2021 · AI

Task V02: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates

$2,467,841
Thomas Rudge · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2022 · AI

Vaccines for prescription opioid and heroin abuse

$2,467,399
Paul Pentel · Hennepin Healthcare Research Institute · U01 · FY2015 · DA

ENHANCEMENT OF THE CPRC-SPF RHESUS MONKEY PROGRAM

$2,467,145
Carlos A Sariol · University Of Puerto Rico Med Sciences · U24 · FY2014 · OD

Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice

$2,465,248
Todd M Allen · Massachusetts General Hospital · P01 · FY2014 · AI

Virus-induced Cell Fate Decisions in Anti-Viral Immunity

$2,465,241
Troy D Randall · University Of Alabama At Birmingham · U19 · FY2015 · AI

BSL3 management and practice of infectious disease research at HTRL

$2,464,978
Dominique M Missiakas · University Of Chicago · UC7 · FY2024 · AI

SPORE in Head and Neck Cancer

$2,464,795
David Sidransky · Johns Hopkins University · P50 · FY2006 · CA

Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit

$2,464,363
Pablo Tebas · University Of Pennsylvania · UM1 · FY2020 · AI

Research Project 2: Therapeutic Human Monoclonal Antibody Treatments for Filoviruses

$2,464,333
James E Crowe · University Of Texas Med Br Galveston · U19 · FY2023 · AI

Development of Novel Therapies for HIV Infection and AIDS-Related Malignancies

$2,463,925
Robert Yarchoan · Clinical Sciences · Z01 · FY2007 · CA

Defining regulators of immunity to acute infection using CRISPR screens

$2,462,939
Arlene H Sharpe · Harvard Medical School · U19 · FY2017 · AI

Vaccine Induced Immunity in the Young and Aged

$2,462,810
Rafi Ahmed · Emory University · U19 · FY2009 · AI

UCLA AIDS Prevention and Treatment Clinical Trials Unit

$2,462,528
Judith S. Currier · University Of California Los Angeles · U01 · FY2010 · AI

Core C: Biosecurity Core

$2,461,801
James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2024 · AI

Optimizing Human B and T Cell Vaccines Against HIV Using Humanized BLT Mice

$2,461,800
Todd M Allen · Massachusetts General Hospital · P01 · FY2015 · AI

Experimental Therapy for Brain Tumors

$2,461,078
John H Sampson · Duke University · P01 · FY2019 · CA

The Institute for Biomolecular Targeting

$2,460,000
Dean R Madden · Dartmouth College · P20 · FY2024 · GM

Novel imaging biomarkers to address fundamental controversies in TB pathogenesis

$2,460,000
Sanjay Jain · Johns Hopkins University · DP2 · FY2009 · OD

The Institute for Biomolecular Targeting

$2,460,000
Dean R Madden · Dartmouth College · P20 · FY2021 · GM

The Institute for Biomolecular Targeting

$2,460,000
Dean R Madden · Dartmouth College · P20 · FY2022 · GM

The Institute for Biomolecular Targeting

$2,460,000
Dean R Madden · Dartmouth College · P20 · FY2025 · GM